Phuong Hoang Diem Nguyen

Phuong Hoang Diem Nguyen

Auto-generated profile, based on publicly available information

Phuong Hoang Diem Nguyen

Department of Pharmacology, Institute for Digital Medicine National University of Singapore Singapore Singapore

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2023 in ACS Nano
Verified
Journal Article
Closed access
PNPhuong Hoang Diem Nguyen
Phuong Hoang Diem Nguyen
MJMigara Kavishka Jayasinghe
Migara Kavishka Jayasinghe
ALAnh Hong Le
Anh Hong Le
BPBoya Peng
Boya Peng
Minh LeMinh Le
Minh Le

17 March 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
PNPhuong H. D. Nguyen
Phuong H. D. Nguyen
MWMartin Wasser
Martin Wasser
CTChong Teik Tan
Chong Teik Tan
CLChun Jye Lim
Chun Jye Lim
HLHannah L. H. Lai
Hannah L. H. Lai
Valerie ChewValerie Chew
Valerie Chew
Immune evasion is key to cancer initiation and later at metastasis, but its dynamics at intermediate stages, where potential therapeutic interventions could be applied, is undefined. Here we show, using multi-dimensional analyses of resected tumours, their adjacent non-tumour tissues and peripheral blood, that extensive immune remodelling takes place in patients with stage I to III hepatocellular carcinoma (HCC). We demonstrate the depletion of anti-tumoural immune subsets and accumulation of immunosuppressive or exhausted subsets along with reduced tumour infiltration of CD8 T cells peaking at stage II tumours. Corresponding transcriptomic modification occur in the genes related to antigen presentation, immune responses, and chemotaxis. The progressive immune evasion is validated in a murine model of HCC. Our results show evidence of ongoing tumour-immune co-evolution during HCC progression and offer insights into potential interventions to reverse, prevent or limit the progression of the disease.

5 July 2022 in Journal of Extracellular Biology
Verified
Journal Article
Open access
PNPhuong H.D. Nguyen
Phuong H.D. Nguyen
ALAnh Hong Le
Anh Hong Le
JPJonetta Shi Qi Pek
Jonetta Shi Qi Pek
TPThach Tuan Pham
Thach Tuan Pham
MJMigara Kavishka Jayasinghe
Migara Kavishka Jayasinghe
Minh LeMinh Le
Minh Le
Blood cell‐derived extracellular vesicles (BCEVs) and lipoproteins are the major circulating nanoparticles in blood that play an important role in intercellular communication. They have attracted significant interest for clinical applications, given their endogenous characteristics which make them stable, biocompatible, well tolerated, and capable of permeating biological barriers efficiently. In this review, we describe the basic characteristics of BCEVs and lipoproteins and summarize their implications in both physiological and pathological processes. We also outline well accepted workflows for the isolation and characterization of these circulating nanoparticles. Importantly, we highlight the latest progress and challenges associated with the use of circulating nanoparticles as diagnostic biomarkers and therapeutic interventions in multiple diseases. We spotlight novel engineering approaches and designs to facilitate the development of these nanoparticles by enhancing their stability, targeting capability, and delivery efficiency. Therefore, the present work provides a comprehensive overview of composition, biogenesis, functions, and clinical translation of circulating nanoparticles from the bench to the bedside.

18 August 2023 in Journal of Extracellular Biology
Verified
Journal Article
Open access
PDF file
CSClarissa Sastrawidjaya
Clarissa Sastrawidjaya
PNPhuong H. D. Nguyen
Phuong H. D. Nguyen
Click on the article title to read more.